Annual long term liabilities:
$723.96M+$10.93M(+1.53%)Summary
- As of today (July 1, 2025), BMRN annual total long term liabilities is $723.96 million, with the most recent change of +$10.93 million (+1.53%) on December 31, 2024.
- During the last 3 years, BMRN annual long term liabilities has fallen by -$468.64 million (-39.30%).
- BMRN annual long term liabilities is now -42.06% below its all-time high of $1.25 billion, reached on December 31, 2020.
Performance
BMRN Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$725.34M+$1.37M(+0.19%)Summary
- As of today (July 1, 2025), BMRN quarterly total long term liabilities is $725.34 million, with the most recent change of +$1.37 million (+0.19%) on March 31, 2025.
- Over the past year, BMRN quarterly long term liabilities has increased by +$14.38 million (+2.02%).
- BMRN quarterly long term liabilities is now -46.26% below its all-time high of $1.35 billion, reached on September 30, 2017.
Performance
BMRN quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BMRN Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.5% | +2.0% |
3 y3 years | -39.3% | -38.6% |
5 y5 years | +14.0% | +9.5% |
BMRN Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -39.3% | +1.5% | -38.7% | +3.9% |
5 y | 5-year | -42.1% | +14.0% | -42.1% | +3.9% |
alltime | all time | -42.1% | >+9999.0% | -46.3% | >+9999.0% |
BMRN Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $725.34M(+0.2%) |
Dec 2024 | $723.96M(+1.5%) | $723.96M(+0.3%) |
Sep 2024 | - | $722.14M(+1.2%) |
Jun 2024 | - | $713.49M(+0.4%) |
Mar 2024 | - | $710.96M(-0.3%) |
Dec 2023 | $713.03M(-39.7%) | $713.03M(+2.1%) |
Sep 2023 | - | $698.04M(-41.0%) |
Jun 2023 | - | $1.18B(+0.6%) |
Mar 2023 | - | $1.18B(-0.6%) |
Dec 2022 | $1.18B(-0.8%) | $1.18B(+0.7%) |
Sep 2022 | - | $1.17B(-0.2%) |
Jun 2022 | - | $1.18B(-0.4%) |
Mar 2022 | - | $1.18B(-1.0%) |
Dec 2021 | $1.19B(-4.6%) | $1.19B(-0.3%) |
Sep 2021 | - | $1.20B(-1.4%) |
Jun 2021 | - | $1.21B(+0.0%) |
Mar 2021 | - | $1.21B(-2.9%) |
Dec 2020 | $1.25B(+96.7%) | $1.25B(-0.0%) |
Sep 2020 | - | $1.25B(-0.2%) |
Jun 2020 | - | $1.25B(+89.0%) |
Mar 2020 | - | $662.41M(+4.3%) |
Dec 2019 | $635.15M(-32.1%) | $635.15M(-35.8%) |
Sep 2019 | - | $989.98M(-0.3%) |
Jun 2019 | - | $993.00M(-0.5%) |
Mar 2019 | - | $997.78M(+6.6%) |
Dec 2018 | $935.95M(-7.1%) | $935.95M(-0.6%) |
Sep 2018 | - | $941.65M(+0.8%) |
Jun 2018 | - | $934.63M(-8.0%) |
Mar 2018 | - | $1.02B(+0.8%) |
Dec 2017 | $1.01B(+23.2%) | $1.01B(-25.3%) |
Sep 2017 | - | $1.35B(+58.8%) |
Jun 2017 | - | $850.08M(+2.5%) |
Mar 2017 | - | $829.31M(+1.4%) |
Dec 2016 | $818.11M(-7.4%) | $818.11M(-0.1%) |
Sep 2016 | - | $819.10M(+1.7%) |
Jun 2016 | - | $805.15M(-18.6%) |
Mar 2016 | - | $988.75M(+12.0%) |
Dec 2015 | $883.06M(+24.1%) | $883.06M(-6.2%) |
Sep 2015 | - | $941.72M(-0.2%) |
Jun 2015 | - | $944.03M(+1.8%) |
Mar 2015 | - | $927.73M(+30.3%) |
Dec 2014 | $711.75M(-1.1%) | $711.75M(-1.9%) |
Sep 2014 | - | $725.44M(+1.2%) |
Jun 2014 | - | $717.00M(-1.0%) |
Mar 2014 | - | $724.57M(+0.7%) |
Dec 2013 | $719.75M(+88.3%) | $719.75M(+308.0%) |
Sep 2013 | - | $176.41M(-12.2%) |
Jun 2013 | - | $201.02M(-1.5%) |
Mar 2013 | - | $204.13M(-46.6%) |
Dec 2012 | $382.15M(-12.9%) | $382.15M(-8.4%) |
Sep 2012 | - | $417.25M(+1.2%) |
Jun 2012 | - | $412.10M(+1.7%) |
Mar 2012 | - | $405.32M(-7.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $438.54M(-5.0%) | $438.54M(+0.3%) |
Sep 2011 | - | $437.28M(-6.2%) |
Jun 2011 | - | $466.05M(-0.3%) |
Mar 2011 | - | $467.32M(+1.3%) |
Dec 2010 | $461.52M(-10.7%) | $461.52M(-18.6%) |
Sep 2010 | - | $566.77M(+5.2%) |
Jun 2010 | - | $538.62M(-0.7%) |
Mar 2010 | - | $542.27M(+4.9%) |
Dec 2009 | $516.82M(+3.4%) | $516.82M(+3.1%) |
Sep 2009 | - | $501.43M(+0.1%) |
Jun 2009 | - | $500.97M(+0.2%) |
Mar 2009 | - | $500.03M(+0.0%) |
Dec 2008 | $499.94M(-11.7%) | $499.94M(-0.1%) |
Sep 2008 | - | $500.40M(-11.4%) |
Jun 2008 | - | $565.11M(-0.0%) |
Mar 2008 | - | $565.23M(-0.1%) |
Dec 2007 | $566.01M(+88.9%) | $566.01M(-0.3%) |
Sep 2007 | - | $567.45M(-0.4%) |
Jun 2007 | - | $569.49M(+131.3%) |
Mar 2007 | - | $246.22M(-17.8%) |
Dec 2006 | $299.59M(+28.9%) | $299.59M(-0.7%) |
Sep 2006 | - | $301.73M(-21.0%) |
Jun 2006 | - | $381.82M(-0.9%) |
Mar 2006 | - | $385.34M(+65.8%) |
Dec 2005 | $232.40M(+0.7%) | $232.40M(+1.0%) |
Sep 2005 | - | $230.00M(-1.7%) |
Jun 2005 | - | $233.99M(+6.1%) |
Mar 2005 | - | $220.47M(-4.5%) |
Dec 2004 | $230.89M(+83.7%) | $230.89M(+3.8%) |
Sep 2004 | - | $222.35M(-0.3%) |
Jun 2004 | - | $222.96M(+77.8%) |
Mar 2004 | - | $125.36M(-0.2%) |
Dec 2003 | $125.67M(+2304.7%) | $125.67M(-0.4%) |
Sep 2003 | - | $126.24M(-1.9%) |
Jun 2003 | - | $128.70M(+2762.5%) |
Mar 2003 | - | $4.50M(-14.0%) |
Dec 2002 | $5.23M(+31.9%) | $5.23M(+79.5%) |
Sep 2002 | - | $2.91M(-15.9%) |
Jun 2002 | - | $3.46M(-1.1%) |
Mar 2002 | - | $3.50M(-11.6%) |
Dec 2001 | $3.96M(+6973.2%) | $3.96M(+2613.0%) |
Sep 2001 | - | $146.00K(-26.3%) |
Jun 2001 | - | $198.00K(+321.3%) |
Mar 2001 | - | $47.00K(-16.1%) |
Dec 2000 | $56.00K(-34.1%) | $56.00K(-11.1%) |
Sep 2000 | - | $63.00K(-7.4%) |
Jun 2000 | - | $68.00K(-11.7%) |
Mar 2000 | - | $77.00K(-9.4%) |
Dec 1999 | $85.00K(-22.7%) | $85.00K(-15.0%) |
Sep 1999 | - | $100.00K(-99.6%) |
Jun 1999 | - | $26.10M(>+9900.0%) |
Mar 1999 | - | $100.00K |
Dec 1998 | $110.00K | - |
FAQ
- What is BioMarin Pharmaceutical annual total long term liabilities?
- What is the all time high annual long term liabilities for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual long term liabilities year-on-year change?
- What is BioMarin Pharmaceutical quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly long term liabilities year-on-year change?
What is BioMarin Pharmaceutical annual total long term liabilities?
The current annual long term liabilities of BMRN is $723.96M
What is the all time high annual long term liabilities for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total long term liabilities is $1.25B
What is BioMarin Pharmaceutical annual long term liabilities year-on-year change?
Over the past year, BMRN annual total long term liabilities has changed by +$10.93M (+1.53%)
What is BioMarin Pharmaceutical quarterly total long term liabilities?
The current quarterly long term liabilities of BMRN is $725.34M
What is the all time high quarterly long term liabilities for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total long term liabilities is $1.35B
What is BioMarin Pharmaceutical quarterly long term liabilities year-on-year change?
Over the past year, BMRN quarterly total long term liabilities has changed by +$14.38M (+2.02%)